Suministro de medicamentos exclusivos: erlotinib (Tarceva), pertuzumab (Perjeta), trastuzumab emtansina (Kadcyla), rituximab SC (Mabthera SC), obinutuzumab (Gazyvaro) (...). Modificación PNSP 42/2019

Contract type	Supplies
CPV	33600000
Awarded to	Roche Farma, S. A. U.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.